Guardant Health Inc (MIL:1GH)
€ 132.02 (0%) Market Cap: 17.17 Bil Enterprise Value: 17.70 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Guardant Health Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2026 / 05:00 PM GMT
Release Date Price: €81.7


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GH.OQ - Guardant Health Inc
Guardant Health Inc at Barclays Global Healthcare Conference
Mar 11, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everybody. I'm Luke Serga. I cover life science tools and diagnostics here at Barclays. With me, I have Amira Lee Pellio, co-CEO, and Mike Bell, CFO of Gardarden Health. I told you I wasn't going to TRY her last name, but I did it anyway.

Thanks again for making it, for having us. Yeah, it's great. I think that I just wanted to come off the jump. I mean, there's a.

Couple of conversations that we've been having around Serena 6, right? A couple of fierce biotech or fierce articles out there around really the kind of the protocol design, etc. But They in that in the articles and in the conversations they've talked about like the clinical utility of discovering the ESR1 mutation and it's
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot